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http://intl.elsevierhealth.com/journals/ijidCommunity-acquired infection due to
Stenotrophomonas maltophilia: a
rare cause of meningitis
Stenotrophomonas maltophilia (previously Pseudo-
monas maltophilia and Xanthomonas maltophilia),
a multiresistant Gram-negative bacillus, is increas-
ingly recognized as an important cause of nosoco-
mial infections,1 although community-acquired
infection with this bacterium is reported rarely.
The microrganism mainly infects severely ill, debili-
tated patients and is most frequent in immunocom-
promised hosts. Infection in immunocompetent
individuals is rare. Stenotrophomonas maltophilia
is associated with an ever-expanding spectrum of
clinical syndromes, but remains extremely rare.1
This correspondence reports an unusual case of
community-acquired meningitis due to S. maltophi-
lia in an immunocompetent adult.
A 49-year-old man, an employee of a horse riding
club, was admitted to the St Anna Hospital with
confusion, headache, fever of 39 8C, rigor, nausea
and vomiting. The patient’s past medical history
was significant for hepatic steatosis. The last time
he had been to a hospital was in 1969 for head
trauma. Physical examination revealed positive
Brudzinski and Lase`gue signs. He had a normal
fundoscopic examination and had no focal neurolo-
gic deficits. The remainder of his examination was
unremarkable.
The laboratory findings showed: white blood cell
count, 21.3  109/L with neutrophils 87%, CRP
21.4 mg/mL, ALT 30 IU/L, total bilirubin 0.6 U/L,
protein 5.9 g/dl with immunoglobulins 8.9%. Chest
X—ray was normal. A cranial computed tomographic
scan demonstrated marked edema in both frontal
regions. Lumbar puncture yielded xanthochromic
fluid which when analyzed showed: white cell count
2.93 109/L (neutrophils 96% and lymphocytes 4%);
glucose 75 mg/dL and protein 501 mg/dL. CSF Gram
staining revealed the presence of Gram-negative
rods. CSF culture yielded a Gram-negative bacillus
which was identified as S. maltophilia. This isolate1201-9712/$30.00 # 2004 International Society for Infectious Disea
doi:10.1016/j.ijid.2004.05.002was susceptible in vitro to ceftazidime, amikacin,
gentamicin, netilmicin, piperacillin, and tobrami-
cin and resistant to amoxicillin/clavulanate,
aztreonam, cefotaxime, ceftriaxone, ciprofloxa-
cin, imipenem and trimethoprim-sulphamethoxa-
zole (agar dilution test). Therapy with ceftazidime
(2 g every eight hours) amikacin (500 mg every
eight hours) and dexamethasone (8 mg every
eight hours) was started immediately. A paranasal
sinus CT revealed interruption of the cribiform
lamina of the ethmoid bone (most likely from
the previous head trauma). The patient’s fever
abated three days later and the other symptoms
disappeared.
CSF analysis ten days later revealed the following
values: white blood cell count 0.001  109/L; glu-
cose level 67 mg/dL; protein level 53 mg/dL. The
fluid culture was sterile. After 14 days of hospita-
lization, he was transferred to the Head Surgery
Unit for reconstruction of the cranial base. No long-
term sequelae were observed.
Meningitis caused by S. maltophilia is uncom-
mon. To date, only fourteen cases have been
reported in the literature (including the present
case) (see Table 1). Eight of these 14 were hospi-
tal-acquired and seven occurred after the patient
had undergone a neurosurgical procedure; the
remaining six were community-acquired.2—12 Four
of these spontaneous episodes occurred in infants
from developing countries, one in an adult with
chronic obstructive pulmonary disease, one in a
younger man with chronic sinusitis and the current
case in an immunocompetent subject without any
apparent risk factors.2—5
The bacterium has been isolated from a wide
range of nosocomial sources and rarely in humans.1
Even less is known about community sources of S.
maltophilia.1 It has been isolated from a number of
water sources including rivers, wells, lake, bottled
water and sewage. The bacterium has also been
recovered from a variety of soils. Food sources for
the microrganism include frozen fish, milk, poultry
eggs and lamb. The bacterium has also been isolatedses. Published by Elsevier Ltd. All rights reserved.
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Table 1 Characteristic of patients with meningitis caused by Stenotrophomonas maltophilia.
Author/Year Case
No.
Age/Sex Comorbidity Origin Therapy Outcome
Patrick/1975 1 70 yrs/M COPD Community Sulfadimidine,
chloramphenicol
Recovered
Denis/1977 2 8 mth/M None Community Ampicillin, colistin Died
Denis/1977 3 13 mth/F None Community Sulfadoxine,
chloramphenicol
Recovered
Trump/1982 4 55 yrs/F Breast cancer/
meningeal metastasis
Nosocomial Chloramphenicol,
gentamicin
Recovered
Sarvamangala
Deri/1984
5 7 days/M Prematurity Community None Died
Muder/1987 6 65 yrs/F Intraventricular bleed Nosocomial TMP—SMX Recovered
Girijaratnakumari/1993 7 28 yrs/F Primary brain tumor Nosocomial Ciprofloxacin Recovered
Nguyen/1994 8 64 yrs/F Meningioma Nosocomial TMP—SMX,
gentamicin
Recovered
Papadakis/1997 9 36 yrs/F Melanoma/
meningeal metastatis
Nosocomial TMP—SMX,
ceftazidime
Recovered
Papadakis/1997 10 41 yrs/M CNS primary lymphoma Nosocomial TMP—SMX,
amikacin
Recovered
Platsouka/2002 11 42 yrs/M Cholesteatoma Nosocomial TMP—SMX,
ceftazidime
Recovered
Lo/2002 12 4 days/F Prematurity Nosocomial Ciprofloxacin Recovered
Spencer/2002 13 31 yrs/F Chronic sinusitis Community TMP—SMX Recovered
Libanore/2003 14 49 yrs/M None Community Ceftazidime,
amikacin
Recovered
TMP—SMX: trimethoprim-sulfamethoxazole.from the faeces and gastrointestinal tract of horses,
cows, rabbits, sows, lizards, frogs, sheep and
snakes.1 Our patient could have acquired the bac-
terium from the ingestion of soil-contaminated
foods or drinking water. The hypothesis that this
patient acquired the microorganism in 1969 during
the previous hospitalization for head trauma is
unlikely.
Resistance to the multiple agents used to treat
Gram-negative infections is a hallmark of S. mal-
tophilia.1 Based on susceptibility studies, trimetho-
prim-sulphamethoxazole (TMP-SMX) is the agent of
choice for treating S. maltophilia infections. How-
ever, recent data suggest that the percentage of
strains resistant to TMP—SMX may be on the rise1
and the present case confirms this observation. The
optimum treatment is not known, nevertheless, the
organism is usually sensitive to ceftazidime, which
is an appropriate initial choice of treatment.
Recently, others have recommended combinations
of ceftazidime and ciprofloxacin despite the in vitro
resistance to the quinolones.12 This microorganism
should be included in differential diagnosis of com-
munity-acquired meningitis in immunocompetent
hosts.
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